Your browser doesn't support javascript.
loading
The Prevalence and Characteristics of Arrhythmic Mitral Valve Prolapse in Patients With Unexplained Cardiac Arrest.
Alqarawi, Wael; Tadros, Rafik; Roberts, Jason D; Cheung, Christopher C; Green, Martin S; Burwash, Ian G; Steinberg, Christian; Healey, Jeffrey S; Khan, Habib; McIntyre, Ciorsti; Cadrin-Touringy, Julia; Laksman, Zachary W M; Simpson, Christopher S; Sanatani, Shubhayan; Gardner, Martin; Angaran, Paul; Ilhan, Erkan; Talajic, Mario; Arbour, Laura; Leather, Richard; Seifer, Colette; Joza, Jacqueline; Lee, Felicity; Lau, Lawrence; Nair, Girish; Wells, George; Krahn, Andrew D.
Afiliación
  • Alqarawi W; Department of Cardiac Sciences, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada. Electronic address: walqarawi@ksu.edu.sa.
  • Tadros R; Cardiovascular Genetics Center, Montreal Heart Institute, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Roberts JD; Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Cheung CC; Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Green MS; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Burwash IG; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Steinberg C; Institut Universitaire de Cardiologie et Pneumologie de Québec, Laval University, Quebec City, Quebec, Canada.
  • Healey JS; Population Health Research Institute, McMaster University, and Hamilton Health Sciences, Hamilton, Ontario, Canada.
  • Khan H; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada.
  • McIntyre C; Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Cadrin-Touringy J; Cardiovascular Genetics Center, Montreal Heart Institute, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Laksman ZWM; Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Simpson CS; Cardiac Electrophysiology Service, Queen's University, Kingston, Ontario, Canada.
  • Sanatani S; Division of Cardiology, BC Children's Hospital, Vancouver, British Columbia, Canada.
  • Gardner M; Dalhousie University and Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada.
  • Angaran P; Cardiac Arrhythmia Service, St-Michael's Hospital, Toronto, Ontario, Canada.
  • Ilhan E; Division of Cardiology, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada.
  • Talajic M; Cardiovascular Genetics Center, Montreal Heart Institute, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  • Arbour L; Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Leather R; Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
  • Seifer C; St-Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Joza J; Division of Cardiology, McGill University Health Center, Montreal, Quebec, Canada.
  • Lee F; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Lau L; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Nair G; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Wells G; Division of Cardiology, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.
  • Krahn AD; Center for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada.
JACC Clin Electrophysiol ; 9(12): 2494-2503, 2023 12.
Article en En | MEDLINE | ID: mdl-37804262
ABSTRACT

BACKGROUND:

There is growing evidence that mitral valve prolapse (MVP) is associated with otherwise unexplained cardiac arrest (UCA). However, reports are hindered by the absence of a systematic ascertainment of alternative diagnoses.

OBJECTIVES:

This study reports the prevalence and characteristics of MVP in a large cohort of patients with UCA.

METHODS:

Patients were enrolled following an UCA, defined as cardiac arrest with no coronary artery disease, preserved left ventricular ejection fraction, and no apparent explanation on electrocardiogram. A comprehensive evaluation was performed, and patients were diagnosed with idiopathic ventricular fibrillation (IVF) if no cause was found. Echocardiography reports were reviewed for MVP. Patients with MVP were divided into 2 groups those with IVF (AMVP) and those with an alternative diagnosis (nonarrhythmic MVP). Patient characteristics were then compared. The long-term outcomes of AMVP were reported.

RESULTS:

Among 571 with an initially UCA, 34 patients had MVP (6%). The prevalence of definite MVP was significantly higher in patients with IVF than those with an alternative diagnosis (24 of 366 [6.6%] vs 5 of 205 [2.4%]; P = 0.03). Bileaflet prolapse was significantly associated with AMVP (18 of 23 [78%] vs 1 of 8 [12.5%]; P = 0.001; OR 25.2). The proportion of patients with AMVP who received appropriate implantable cardioverter-defibrillator therapies over a median follow-up of 42 months was 21.1% (4 of 19).

CONCLUSIONS:

MVP is associated with otherwise UCA (IVF), with a prevalence of 6.6%. Bileaflet prolapse appears to be a feature of AMVP, although future studies need to ascertain its independent association. A significant proportion of patients with AMVP received appropriate implantable cardioverter-defibrillator therapies during follow-up.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prolapso de la Válvula Mitral / Paro Cardíaco Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JACC Clin Electrophysiol Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Prolapso de la Válvula Mitral / Paro Cardíaco Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: JACC Clin Electrophysiol Año: 2023 Tipo del documento: Article
...